Cargando…
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
Despite combined treatments, glioblastoma outcome remains poor with frequent local recurrences, indicating that a more efficient and local therapy is needed. In this way, vascular-targeted photodynamic therapy (VTP) could help tumor eradication by destroying its neovessels. In this study, we designe...
Autores principales: | Thomas, Eloïse, Colombeau, Ludovic, Gries, Mickaël, Peterlini, Thibaut, Mathieu, Clélia, Thomas, Noémie, Boura, Cédric, Frochot, Céline, Vanderesse, Régis, Lux, François, Barberi-Heyob, Muriel, Tillement, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627731/ https://www.ncbi.nlm.nih.gov/pubmed/29026302 http://dx.doi.org/10.2147/IJN.S141559 |
Ejemplares similares
-
Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma
por: Gries, Mickaël, et al.
Publicado: (2020) -
Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX(®)-Design Nanoparticles
por: Lerouge, Lucie, et al.
Publicado: (2023) -
AGuIX(®) from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine
por: Lux, François, et al.
Publicado: (2019) -
Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging
por: Thakare, Vivek, et al.
Publicado: (2019) -
EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles
por: Bort, Guillaume, et al.
Publicado: (2020)